Brief: Piramal Pharma To Reduce GHG Emissions By 2030
17/09/2024 05:45
Sept 17 (Reuters) - Piramal Pharma Ltd PIRM.NS :
* PIRAMAL PHARMA - RECEIVED SBTI APPROVAL FOR COMMITMENT TO
REDUCE
SCOPE 1 AND 2 GHG EMISSIONS BY 42% AND SCOPE 3 BY 25% BY FY 2030
Source text for Eikon: ID:nBSEccwrM7
Further company coverage: PIRM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma (Mumbai) Says Commercial Arrangement With Bayer Pharmaceuticals To Expire On December 31, 2026
Brief: Piramal Pharma (Mumbai) Says Tax Authority Confirms Demand Of 40.6 Million Rupees And Imposes Equivalent Penalty
India's Piramal Pharma falls after US FDA observations at UK facility
Brief: Piramal Pharma Says US FDA Issues Form-483 With 7 Observations To Morpeth UK Facility
Brief: Piramal Pharma Approves Exercise Of Call Option For Acquisition Of Additional 41% Equity In Yapan Bio